Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase.
- Authors
- Manoharan, I; Kuznetsova, A; Fisk, J D; Boopathy, R; Lockridge, O; Darvesh, S
- Year
- 2007
- Journal
- Journal of neural transmission (Vienna, Austria : 1996)
- PMID
- 17318303
- DOI
- 10.1007/s00702-007-0631-x
In the human brain, butyrylcholinesterase (BuChE) is expressed in neurons and glia. For example, many nuclei in the human thalamus, with projections to the cerebral cortex, contain a large number of neurons with intense BuChE activity. Thalamocortical projections subserve a variety of cognitive functions. Due to genetic mutations, there are individuals who do not have detectable BuChE activity (silent BuChE). While the prevalence of silent BuChE is only 1:100,000 in European and American populations, it is 1:24 in the Vysya community in Coimbatore, India. To examine whether there are differences in cognitive functions between individuals with silent BuChE and those expressing normal BuChE (wild-type), twelve healthy individuals with silent BuChE and thirteen healthy individuals with wild-type BuChE, all from the Vysya community in Coimbatore, were tested for cognitive function using the Automated Neuropsychological Assessment Metrics test battery. The silent BuChE group was slightly faster on simple reaction tasks, but slower on a visual perceptual matching task. Furthermore, discriminant function analyses correctly classified 11/12 silent and 8/13 wild-type BuChE subjects (76% correct classification overall) based on BuChE status. Different profiles of cognitive test performance between individuals with silent and wild-type BuChE were observed. These observations suggest a function for BuChE in cognition.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | 2017 | 28070124 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | Meyers JL et al. | — | 2017 | → |
| Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves <sup>18</sup>FDG retention in 5XFAD mouse model of Alzheimer's disease. | DeBay DR et al. | — | 2017 | → |
| Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank. | Howard DM et al. | — | 2017 | → |
| Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse. | Maurice T et al. | — | 2016 | → |
| New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter. | Jońca J et al. | — | 2015 | → |
| Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. | Jacob CP et al. | — | 2013 | → |
| An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study. | David SM et al. | — | 2013 | → |
| A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. | Nordberg A et al. | — | 2013 | → |
| Effect of viologen-phosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities. | Ciepluch K et al. | — | 2013 | → |
| Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene. | Johnson G et al. | — | 2012 | → |
| Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. | Lesch KP et al. | — | 2011 | → |
| N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease. | González-Muñoz GC et al. | — | 2011 | → |
| Altered levels of acetylcholinesterase in Alzheimer plasma. | García-Ayllón MS et al. | — | 2010 | → |
| Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. | Carolan CG et al. | — | 2010 | → |
| Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases. | González-Muñoz GC et al. | — | 2010 | → |
| The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease. | Duysen EG et al. | — | 2009 | → |